Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers ...

Use these social-bookmarking links to share Enzyme can block tumour-feeding blood vessels. Use this form to email 'Enzyme can block tumour-feeding blood vessels' to someone you know: ...

The study focused on PGK1, a “rate-limiting” enzyme essential for energy production in the axons of dopamine-producing neurons, which are severely affected in Parkinson’s disease.